Biopharma Stocks Face Rising ESG Risks. What's an Investor t

Moats can help. Attractive opportunities in Bayer, GSK, and Roche.

Related Keywords

Morningstar Sustainalytics , Glaxosmithkline , Access To Basic Services , Access To Basic Service , Institute For Clinical , Inflation Reduction Act , Basic Services , Basic Service , Total Revenue , Drug Pricing Risk , Economic Review , Assessing Firms , Cost Effect Drug , Morningstar Uncertainty Ratings , Uncertainty Rating , Safety Can Lead , Litigation Costs Compared , Morningstar Economic Moat Rating , Wide Moat Roche ,